Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells

Pharmacology and Toxicology

Volumn 86, Issue 2, 2000, Pages 83-91

  Wang, Ing Kae ^a   Lin Shiau, Shoei Yn ^a   Lin, Jen Kun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE INHIBITOR; CYTOCHROME C OXIDASE; DEOXYRIBONUCLEASE II; DNA FRAGMENT; MEVALONIC ACID; MEVALONOLACTONE; MEVINOLIN; MITOCHONDRIAL ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME RELEASE; HUMAN; HUMAN CELL; ISOPRENYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033982224     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-16.x     Document Type: Article

References (39)

1. Arellano R. & S. Grinslein: Role of isoprenylation in intracellular pH regulation of granulocytes. FEBS Lett. 1993, 332, 247 250.
2. Barry M. A. & A. Eastman: Identification of deoxyribonuclease II as an endonuclease involved inapoptosis. Arch. Biochem. Biophys. 1993, 300, 440-450.
3. Casey, P. J.: Biochemistry of protein prenylation. J. Lipid Res. 1992, 33, 1731-1740.
4. Chang, M.Y., M.S. Jan, S.J. Won & H.S. Liu: Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin. Biochem. Biophys. Res. Commun. 1998, 248, 62-68.
5. Cotter, T.G., J.M. Glynn, F. Echeverri & D.R. Green: The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 1992, 12, 773-779.
6. Dive, C. & J.A. Hickman: Drug-target interactions: only the first step in the commitment to a programmed cell death? Brit. J. Cancer 1991, 64, 192-196.
7. Enari, M., A. Hase & S. Nagata: Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 1995, 14, 5201-5208.
8. Enari, M., H. Sakahira, H Yokoyama., K. Okawa, A. Iwamatsu & S. Nagata: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998, 391, 43-50.
9. Faucheu, C., A. Diu, A.W. Chan, A.M. Blanchet, C. Miossec, F. Herve, V. Collard-Dutilleul, Y. Gu, R.A. Aldape, J.A. Lippke, C. Rocher, S.-S. Su M., D.J. Livingston, T. Hercend & J.L. Lalanne: A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 1995, 14, 1914-1922.
10. Gunji, H., S. Kharbanda & D. Kufe: Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1991, 51, 741-743.
11. Jakobisiak, M., S. Bruno, J.S. Skierski & Z. Darzynkiewicz: Cell cycle-specific effects of lovastatin. Proc. Natl. Acad. Sci. USA 1991, 88, 3628-3632.
12. Jones, K.D., W.T. Couldwell, D.R. Hinton, Y. Su, S. He, L. Anker & R.E. Law: Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem. Biophys. Res. Commun. 1994, 205, 1681-1687.
13. Kaufmann, S.H., S. Desnoyers, Y. Ottaviano, N.E. Davidson & G.G. Poirier: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993, 53, 3976-3985.
14. Kerr, J.F., A.H. Wyllie & A.R. Currie: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit. J. Cancer 1972, 26, 239-257.
15. Keyomarsi, K., L. Sandovall, V. Band & A.B. Pardee: Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 1991, 51, 3602-3609.
16. Kimura, C., Q.L. Zhao, T. Kondo, M. Amatsu & Y. Fujiwara: Mechanism of UV-induced apoptosis in human leukemia cells: roles of Ca2+/Mg(2+)-dependent endonuclease, caspase-3, and stress-activated protein kinases. Exp. Cell. Res. 1998, 239, 411-422.
17. Kumar, S. & N.L. Harvey: Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 1995, 375, 169-173.
18. Lazebnik, Y.A., S.H. Kaufmann, S. Desnoyers, G.G. Poirier & W.C. Earnshaw: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371, 346-347.
19. Marcelli, M., G.R. Cunningham, S.J. Haidacher, S.J. Padayatty, L. Sturgis, C. Kagan & L. Denner: Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 1998, 58, 76-83.
20. Martin, S.J. & D.R. Green: Protease activation during apoptosis: death by a thousand cuts? Cell 1995, 82, 349-352.
21. Martin, S.J., D.D. Newmeyer, S. Mathias, D.M. Farschon, H.G. Wang, J.C. Reed, R.N. Kolesnick & D.R. Green: Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J. 1995, 14, 5191-5200.
22. st ed Eds.: R.K. Murray, D.K. Granner, P.A. Mayes, V.W. Rodwell. East Norwalk, CT, Lange Medical Publication, 1988, 241-252.
23. Mcgowan, A.J., R.S. Fernandes, S. Verhaegen & T.G. Cotter: Zinc inhibits UV radiation-induced apoptosis but fails to prevent subsequent cell death. Int. J. Radiat. Biol. 1994, 66, 343-349.
24. Munro, E., M. Patel, P. Chan, L. Betteridge, G. Clunn, K. Gallagher, A. Hughes, M. Schachter, J. Wolfe & P. Sever: Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis. Eur. J. Clin. Invest. 1994, 24, 766-772.
25. Nagata, S.: Apoptosis by death factor. Cell 1997, 88, 355-365.
26. Ng, L.L. & J.E. Davies: HMG CoA reductase inhibitors affect Na(+)-H+ antiport activity in human lymphoblasts. Amer. J. Physiol 1991, 261, C780-786.
27. Padayatty, S.J, M. Marcelli, T.C. Shao & G.R. Cunningham: Lovastatin-induced apoptosis in prostate stromal cells. J. Clin. Endocrin. Metab. 1997, 82, 1434-1439.
28. Peitsch, M.C., B. Polzar, H. Stephan, T. Crompton, H.R. Macdonald, H.G. Mannherz & J. Tschopp: Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. 1993, 12, 371-377.
29. Perez-Sala, D. & F. Mollinedo: Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem. Biophys. Res. Commun. 1994, 199, 1209-1215.
30. Perez-Sala, D., D. Collado-Escobar & F. Mollinedo: Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease. J. Biol. Chem. 1995, 270, 6235-6242.
31. Sakahira, H., M. Enari & S. Nagata: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998, 391, 96 99.
32. Shiokawa, D., H. Ohyama, T. Yamada, K. Takahashi & S-T. Tanuma: Identification of an endonuclease responsible for apoptosis in rat thymocytes. Eur. J. Biochem. 1994, 226, 23-30.
33. Siee, E.A., H. Zhu, S.C. Chow, M. Macfarlane, D.W. Nicholson & G.M. Cohen: Benzyloxycarbonyl-Vai-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 1996, 315, 21-24.
34. Srinivasula, S.M., M. Ahmad, T. Fernandes-Alnemri, G. Litwack & E.S. Alnemri: Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA 1996, 93, 14486-14491.
35. Strand, S., W.J. Hofmann, H. Hug, M. Muller, G. Otto, D. Strand, S.M. Mariani, W. Stremmel, P.H. Krammer & P.R. Galle: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat. Med. 1996, 2, 1361-1366.
36. Takahashi, A., E.S. Alnemri, Y.A. Lazebnik, T. Fernandes-Alnemri, G. Litwack, R.D. Moir, R.D. Goldman, G.G. Poirier, S.H. Kaufmann & W.C. Earnshaw: Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA 1996, 93, 8395-8400.
37. Tewari, M., L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D.R. Beidler, G.G. Poirier, G.S. Salvesen & V.M. Dixit: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable-protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995, 81, 801-809.
38. Tobert, J.A., G. Hitzenberger, W.R. Kukovetz,, I.B. Holmes & K.H. Jones: Rapid and substantial lowering of human serum cholesterol by mevinoli (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase. Atherosclerosis 1982, 41, 61-65.
39. Wyllie, A.: Apoptosis. An endonuclease at last. Nature 1998, 391, 20-21.